Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Revenue

Biotechnology Assets had revenue of 1.19M EUR in the half year ending June 30, 2025, a decrease of -27.25%. This brings the company's revenue in the last twelve months to 3.05M, down -9.48% year-over-year. In the year 2024, Biotechnology Assets had annual revenue of 2.97M, down -24.13%.

• Revenue (ttm): 3.05M
• Revenue Growth: -9.48%
• P/S Ratio: 6.40
• Revenue / Employee: 101.77K
• Employees: 34
• Market Cap: 19.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.97M	-943.29K	-24.13%
Dec 31, 2023	3.91M	950.58K	32.14%
Dec 31, 2022	2.96M	-324.07K	-9.87%
Dec 31, 2021	3.28M	390.31K	13.50%
Dec 31, 2020	2.89M	-345.59K	-10.68%